{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T11:13:25Z","timestamp":1783509205266,"version":"3.55.0"},"reference-count":43,"publisher":"Bioscientifica","issue":"3","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060152"],"award-info":[{"award-number":["82060152"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"publisher","award":["24JRRA596"],"award-info":[{"award-number":["24JRRA596"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,1]]},"abstract":"<jats:p>Graves\u2019 disease (GD) is an important risk factor for secondary osteoporosis (OP). Thyrotropin-receptor stimulating antibody (TSAb) is a pathogenic antibody detected in patients with GD. However, few studies have examined the effects of TSAb on bone. Consequently, this study aimed to explore the effect of TSAb on osteoblast differentiation and its possible mechanisms. MC3T3-E1 cells were treated with different concentrations of TSAb. The relative survival rate of cells was assessed using the cell counting kit-8 (CCK-8) assay. Osteoblast differentiation markers were determined using western blotting and immunofluorescence assays. To further evaluate the roles of TSAb in osteogenesis in vivo, a GD-induced OP mouse model was generated by Ad-TSHR289 immunization followed by intragastric administration of methimazole (MMI). Femurs were collected for micro-CT scanning and histomorphometry analysis. The viability of MC3T3-E1 cells did not significantly change with increasing TSAb concentrations. The protein levels of osteoblast differentiation markers (OCN, Col1a1, Runx2, and OPN) in MC3T3-E1 cells treated with 1 and 10 ng\/mL TSAb were significantly reduced. Furthermore, TSAb significantly promoted the AKT\/mTOR pathway. Moreover, inhibition of this signaling pathway attenuated the phosphorylation of AKT and mTOR enhanced by TSAb and reversed osteoblast differentiation. GD mice treated with MMI exhibited reduced bone mass and degraded bone formation. TSAb exacerbates bone loss in GD mice. These findings demonstrated that TSAb inhibits osteoblast differentiation by activating the AKT\/mTOR pathway. This study revealed a novel function of TSAb in regulating osteoblast activity.<\/jats:p>","DOI":"10.1530\/joe-24-0223","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T14:39:04Z","timestamp":1747060744000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-5","source":"Crossref","is-referenced-by-count":0,"title":["TSAb inhibits osteogenic differentiation of MC3T3-E1 cells and exacerbates bone loss in Graves\u2019 disease mice"],"prefix":"10.1530","volume":"265","author":[{"given":"Suhong","family":"Wei","sequence":"first","affiliation":[{"name":"The First School of Clinical Medical, Lanzhou University 1 , ,","place":["Lanzhou, China"]},{"name":"Department of Endocrinology, Gansu Provincial Hospital 2 , ,","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruilan","family":"Niu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Gansu Provincial Hospital 2 , ,","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqi","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Gansu Provincial Hospital 2 , ,","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4769-4375","authenticated-orcid":true,"given":"Limin","family":"Tian","sequence":"additional","affiliation":[{"name":"The First School of Clinical Medical, Lanzhou University 1 , ,","place":["Lanzhou, China"]},{"name":"Department of Endocrinology, Sichuan Provincial People\u2019s Hospital, University of Electronic Science and Technology of China 3 , ,","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"key":"2026070806130685900_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0092-8674(03)00771-2","article-title":"TSH is a negative regulator of skeletal remodeling","volume":"115","author":"Abe","year":"2003","journal-title":"Cell"},{"key":"2026070806130685900_bib2","doi-asserted-by":"crossref","first-page":"842","DOI":"10.2310\/JIM.0b013e31828fcafb","article-title":"The negative correlation between thyrotropin receptor\u2013stimulating antibodies and bone mineral density in postmenopausal patients with Graves\u2019 disease","volume":"61","author":"Amashukeli","year":"2013","journal-title":"J Invest Med"},{"key":"2026070806130685900_bib3","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1210\/me.2007-0221","article-title":"A lack of thyroid hormones rather than excess thyrotropin causes abnormal skeletal development in hypothyroidism","volume":"22","author":"Bassett","year":"2008","journal-title":"Mol Endocrinol"},{"key":"2026070806130685900_bib4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/er.2015-1106","article-title":"Role of thyroid hormones in skeletal development and bone maintenance","volume":"37","author":"Bassett","year":"2016","journal-title":"Endocr Rev"},{"key":"2026070806130685900_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0378-5122(00)00179-1","article-title":"Early postmenopausal bone loss in hyperthyroidism","volume":"39","author":"Ben-Shlomo","year":"2001","journal-title":"Maturitas"},{"key":"2026070806130685900_bib6","first-page":"1","article-title":"Mechanisms and treatment options for hyperthyroid-induced osteoporosis: a narrative review","volume":"15","author":"Branstetter","year":"2023","journal-title":"Cureus"},{"key":"2026070806130685900_bib7","doi-asserted-by":"crossref","first-page":"R261","DOI":"10.1530\/EJE-18-0678","article-title":"Anniversary review: antithyroid drug therapy: 70 years later","volume":"179","author":"Burch","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"2026070806130685900_bib8","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1172\/JCI200317069","article-title":"The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim","volume":"111","author":"Chen","year":"2003","journal-title":"J Clin Invest"},{"key":"2026070806130685900_bib9","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.etap.2017.07.007","article-title":"Emodin suppresses cadmium-induced osteoporosis by inhibiting osteoclast formation","volume":"54","author":"Chen","year":"2017","journal-title":"Environ Toxicol Pharmacol"},{"key":"2026070806130685900_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0144599","article-title":"The presence of thyroid-stimulation blocking antibody prevents high bone turnover in untreated premenopausal patients with Graves\u2019 disease","volume":"10","author":"Cho","year":"2015","journal-title":"PLoS One"},{"key":"2026070806130685900_bib11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jocd.2018.10.006","article-title":"Progressive sublesional bone loss extends into the second decade after spinal cord injury","volume":"22","author":"Cirnigliaro","year":"2019","journal-title":"J Clin Densitom"},{"key":"2026070806130685900_bib12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1677\/joe.0.1510231","article-title":"Serial analysis of the effects of methimazole therapy on circulating B cell subsets in Graves\u2019 disease","volume":"151","author":"Corrales","year":"1996","journal-title":"J Endocrinol"},{"key":"2026070806130685900_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12902-021-00715-8","article-title":"Thyroid-stimulating hormone decreases the risk of osteoporosis by regulating osteoblast proliferation and differentiation","volume":"21","author":"Deng","year":"2021","journal-title":"BMC Endocr Disord"},{"key":"2026070806130685900_bib14","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1210\/jc.2018-00509","article-title":"Stimulatory TSH-receptor antibodies and oxidative stress in Graves disease","volume":"103","author":"Diana","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070806130685900_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000508790","article-title":"A novel long-term Graves\u2019 disease animal model confirmed by functional thyrotropin receptor antibodies","volume":"9","author":"Diana","year":"2020","journal-title":"Eur Thyroid J"},{"key":"2026070806130685900_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-6614-6-11","article-title":"Negative correlation between bone mineral density and TSH receptor antibodies in long-term euthyroid postmenopausal women with treated Graves\u2019 disease","volume":"6","author":"Ercolano","year":"2013","journal-title":"Thyroid Res"},{"key":"2026070806130685900_bib17","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1359\/jbmr.070420","article-title":"Inactivation of Pten in osteo-chondroprogenitor cells leads to epiphyseal growth plate abnormalities and skeletal overgrowth","volume":"22","author":"Ford-Hutchinson","year":"2007","journal-title":"J Bone Miner Res"},{"key":"2026070806130685900_bib18","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.celrep.2017.01.025","article-title":"Quantitative map of proteome dynamics during neuronal differentiation","volume":"18","author":"Frese","year":"2017","journal-title":"Cell Rep"},{"key":"2026070806130685900_bib19","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.4049\/jimmunol.1500183","article-title":"Graves\u2019 disease TSHR-stimulating antibodies (TSAbs) induce the activation of immature thymocytes: a clue to the riddle of TSAbs generation?","volume":"194","author":"Gim\u00e9nez-Barcons","year":"2015","journal-title":"J Immunol"},{"key":"2026070806130685900_bib20","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4248\/BR201302004","article-title":"Role and mechanisms of actions of thyroid hormone on the skeletal development","volume":"1","author":"Kim","year":"2013","journal-title":"Bone Res"},{"key":"2026070806130685900_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/thy.2009.0278","article-title":"A stimulatory thyrotropin receptor antibody (M22) and thyrotropin increase interleukin-6 expression and secretion in Graves\u2019 orbital preadipocyte fibroblasts","volume":"20","author":"Kumar","year":"2010","journal-title":"Thyroid"},{"key":"2026070806130685900_bib22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1530\/JME-11-0006","article-title":"A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves\u2019 ophthalmopathy","volume":"46","author":"Kumar","year":"2011","journal-title":"J Mol Endocrinol"},{"key":"2026070806130685900_bib23","first-page":"4157","article-title":"Persistent increase in bone turnover in Graves\u2019 patients with subclinical hyperthyroidism","volume":"85","author":"Kumeda","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070806130685900_bib24","first-page":"10","article-title":"Expression and significance of thyroid stimulating hormone receptor in ex-trathyroidal tissues","volume":"41","author":"Liu","year":"2021","journal-title":"Int J Endocrinol Metabol"},{"key":"2026070806130685900_bib25","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1159\/000528357","article-title":"TSAb modulates microglia M1 polarization via activation of the TSHR-mediated NF-\u03baB signaling pathway","volume":"113","author":"Liu","year":"2023","journal-title":"Neuroendocrinology"},{"key":"2026070806130685900_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1210\/jcem-62-1-117","article-title":"T lymphocyte subsets at various stages of hyperthyroid Graves\u2019 disease: effect of carbimazole treatment and relationship with thyroid-stimulating antibody levels or HLA status","volume":"62","author":"Madec","year":"1986","journal-title":"Clin Endocrinol Metab"},{"key":"2026070806130685900_bib27","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00198-006-0091-4","article-title":"Negative correlation between bone mineral density and TSH receptor antibodies in male patients with untreated Graves\u2019 disease","volume":"17","author":"Majima","year":"2006","journal-title":"Osteoporos Int"},{"key":"2026070806130685900_bib28","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1089\/thy.2010.0457","article-title":"The influence of thyroid-stimulating hormone and thyroid-stimulating hormone receptor antibodies on osteoclastogenesis","volume":"21","author":"Ma","year":"2011","journal-title":"Thyroid"},{"key":"2026070806130685900_bib29","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1021\/acs.jproteome.0c00992","article-title":"Human bone proteomes before and after decomposition: investigating the effects of biological variation and taphonomic alteration on bone protein profiles and the implications for forensic proteomics","volume":"20","author":"Mickleburgh","year":"2021","journal-title":"J Proteome Res"},{"key":"2026070806130685900_bib30","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1210\/jc.2008-2134","article-title":"Evidence that shed thyrotropin receptor A subunits drive affinity maturation of autoantibodies causing Graves\u2019 disease","volume":"94","author":"Mizutori","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070806130685900_bib31","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1210\/en.2010-0424","article-title":"Neutral antibodies to the TSH receptor are present in Graves' disease and regulate selective signaling cascades","volume":"151","author":"Morshed","year":"2010","journal-title":"Endocrinology"},{"key":"2026070806130685900_bib32","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1210\/en.2008-0878","article-title":"Characterization of thyrotropin receptor antibody-induced signaling cascades","volume":"150","author":"Morshed","year":"2009","journal-title":"Endocrinology"},{"key":"2026070806130685900_bib33","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.3390\/cells9091959","article-title":"Proteomic profiling of extracellular vesicles derived from cerebrospinal fluid of Alzheimer\u2019s disease patients: a pilot study","volume":"9","author":"Muraoka","year":"2020","journal-title":"Cells"},{"key":"2026070806130685900_bib34","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1359\/jbmr.070302","article-title":"Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats","volume":"22","author":"Sampath","year":"2007","journal-title":"J Bone Miner Res"},{"key":"2026070806130685900_bib35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.20945\/2359-3997000000027","article-title":"TSH-receptor antibodies may prevent bone loss in pre-and postmenopausal women with Graves\u2019disease and Graves\u2019orbitopathy","volume":"62","author":"Siderova","year":"2018","journal-title":"Arch Endocrinol Metab"},{"key":"2026070806130685900_bib36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12902-019-0363-6","article-title":"Comparison of Five TSH-Receptor Antibody Assays in Graves\u2019 disease: results from an observational pilot study","volume":"19","author":"Struja","year":"2019","journal-title":"BMC Endocr Disord"},{"key":"2026070806130685900_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/jendso\/bvab042","article-title":"Clinical course of euthyroid subjects with positive TSH receptor antibody: how often does Graves\u2019 disease develop?","volume":"5","author":"Suzuki","year":"2021","journal-title":"J Endocr Soc"},{"key":"2026070806130685900_bib38","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00223-003-0108-3","article-title":"Weak evidence of thyrotropin receptors in primary cultures of human osteoblast-like cells","volume":"74","author":"Tsai","year":"2004","journal-title":"Calcif Tissue Int"},{"key":"2026070806130685900_bib39","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1089\/105072503322238854","article-title":"Hyperthyroidism, bone mineral, and fracture risk\u2013a meta-analysis","volume":"13","author":"Vestergaard","year":"2003","journal-title":"Thyroid"},{"key":"2026070806130685900_bib40","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1167\/iovs.19-27865","article-title":"TSHR signaling stimulates proliferation through PI3K\/akt and induction of miR-146a and miR-155 in thyroid eye disease orbital fibroblasts","volume":"60","author":"Woeller","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2026070806130685900_bib41","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3109\/10799893.2015.1041647","article-title":"The PI3K\/AKT cell signaling pathway is involved in regulation of osteoporosis","volume":"35","author":"Xi","year":"2015","journal-title":"J Receptor Signal Transduction Res"},{"key":"2026070806130685900_bib42","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1089\/105072501750302886","article-title":"Antithyroid drugs inhibit in-vivo HLA-DR expression in thyroid follicular cells in Graves\u2019 disease","volume":"11","author":"Zantut-Wittmann","year":"2001","journal-title":"Thyroid"},{"key":"2026070806130685900_bib43","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1210\/jc.2011-1299","article-title":"Adipose tissue depot-specific differences in the regulation of hyaluronan production of relevance to Graves\u2019 orbitopathy","volume":"97","author":"Zhang","year":"2012","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/joe.bioscientifica.com\/view\/journals\/joe\/265\/3\/JOE-24-0223.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/joe.bioscientifica.com\/downloadpdf\/journals\/joe\/265\/3\/JOE-24-0223.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/joe\/article-pdf\/doi\/10.1530\/JOE-24-0223\/45107\/joe-24-0223.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/joe\/article-pdf\/doi\/10.1530\/JOE-24-0223\/45107\/joe-24-0223.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T10:13:29Z","timestamp":1783505609000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/joe\/article\/265\/3\/e240223\/5742\/TSAb-inhibits-osteogenic-differentiation-of-MC3T3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6,1]]}},"URL":"https:\/\/doi.org\/10.1530\/joe-24-0223","relation":{},"ISSN":["1479-6805","0022-0795"],"issn-type":[{"value":"1479-6805","type":"electronic"},{"value":"0022-0795","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,12]]},"article-number":"e240223"}}